Comparative effectiveness and safety of risankizumab vs ustekinumab in patients with Crohn&#39;s disease: a propensity score-matched multicenter retrospective cohort study.

Stelara (ustekinumab) - J&J

Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim

http://www.ncbi.nlm.nih.gov/pubmed/42730438

Bisher Sawaf; Elias Batikh; Kyrillos Mahrous Gerges; Miguel Regueiro; Mohammad Al-Haddad; Mohammed Abu-Rumaileh; Muhammed Elhadi; Nwal Hadaki; Shahem Abbarh; Umberto Battistin; Yusuf Hallak

Sep 13, 2026